Medscape Cites AHRP Concerns Re: New Law Mandates More Testing of Drugs in Children

Medscape Cites AHRP Concerns Re: New Law Mandates More Testing of Drugs in Children Wed, 17 Dec 2003 Medscape Medical News reports about passage of the Pediatric Research Equity Act (PREA) which replaces FDA’s Pediatric Rule. The Pediatric Rule was struck down by a Federal court in Oct. 2002 because…

Natrecor found to worsen kidney function, hasten death – NYT

Natrecor found to worsen kidney function, hasten death – NYT Tue, 17 May 2005 Natrecor, a drug approved by the FDA for treating patients with heart failure, is being widely prescribed off label for unapproved uses. The drug is prescribed for so-called “tune-ups” in outpatient clinics – although that use…

Pfizer CEO earned $16 milion – 72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs

Pfizer CEO earned $16 milion-72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs Thu, 10 Mar 2005 In his February 16 testimony before the Senate Committee on Health, Education, Labor and Pensions, Dr. Peter Rost, Pfizer V-P for Marketing, said: “Every day Americans die…

Infomail Archive 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

Charitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal

Charitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal Tue, 8 Mar 2005 The Washington Post reports that conservatives have crafted a “bioethics agenda” on cloning and stem cell research. Such an agendaq determines what research the government will and will not fund. http://www.washingtonpost.com/wp-dyn/articles/A15569-2005Mar7.html Below is an excerpt of…

AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme

AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme Sun, 22 Jun 2003 AstraZeneca agreed to a $355 million settlement in civil and criminal charges. Government prosecutors found that AstraZeneca reported to the government that the average wholesale price for a monthly dose of the prostate cancer drug, Zoladex, was about…

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today Tue, 26 Apr 2005 USA Today provides a glimpse into the way the pharmaceutical industry controls health care policy by buying influence at the highest level of government, and underwriting professional and lay healthcare organizations whose spokespersons parrot industry’s…

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost

DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost Wed, 5 Jan 2005 Dr. Peter Rost, a Pfizer Vice-President of Marketing knows about the financial underpinnings of drug pricing. He has taken a consciencious public position (unsusual in that industry) because he believes the American public has a…

| |

UK: Drugs firms ‘creating ills for every pill / US ‘Bioshield’ Drug-Patent Plan Draws Fire

UK: Drugs firms ‘creating ills for every pill / US ‘Bioshield’ Drug-Patent Plan Draws Fire Mon, 04 Apr 2005 Following the public revelations about the concealed safety hazards of antidepressant drugs whose risks of violence, drug dependency, and suicide, were hidden from physicians and the public, a committee of Parliament…

Serono to pay $704 million for Illegal Marketing AIDS drug and "voodoolike" clinical trials – NYT

Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…

A Serious Drug Problem – The Medicare Prescription Bill of 2003 – Krugman

A Serious Drug Problem – The Medicare Prescription Bill of 2003 – Krugman Fri, 6 May 2005 New York Times columnist, Paul Krugman, hits the nail on the head when he points out who the beneficiaries of the Medicare law really are: Why it’s Big Pharma and those this industry…